CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award President and CEO acquired 45,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Executive or director change · Other events
- 4 Open-market sale President and CEO sold 3,038 shares at an average $6.63 ($20,139)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 1,821 shares at an average $6.63 ($12,072)
- 4 Open-market sale EVP, Chief Legal Officer sold 1,158 shares at an average $6.63 ($7,677)
- 4 Open-market sale EVP, CFO sold 1,070 shares at an average $6.63 ($7,093)
- 4 Open-market sale EVP, Global Head RA & Quality sold 963 shares at an average $6.63 ($6,384)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 57 · 1,133 filings